atenolol and aliskiren

atenolol has been researched along with aliskiren in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Corynen, S; Dieterle, W; Mann, J; Vaidyanathan, S	1
Aubert, JF; Bouzourene, K; Hayoz, D; Mazzolai, L; Nussberger, J; Pellegrin, M	1
Bheda, M; Dechend, R; Dietz, R; Ford, J; Keefe, DL; Prescott, MF; Yu, CM	1
Ahn, J; Carriere, K; Chang, SA; Choe, YH; Chung, TY; Hwang, JW; Jang, SY; Ki, CS; Kim, DK; Kim, EK; Kim, SM; Sung, K	1

Reviews

1 review(s) available for atenolol and aliskiren

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

3 trial(s) available for atenolol and aliskiren

Article	Year
Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine. International journal of clinical pharmacology and therapeutics, 2005, Volume: 43, Issue:11 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amides; Atenolol; Celecoxib; Cimetidine; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Drug Interactions; Enzyme Inhibitors; Fumarates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lovastatin; Male; Middle Aged; Pyrazoles; Renin; Sulfonamides	2005
Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2008, Volume: 9, Issue:3 Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Atenolol; Blood Pressure; Demography; Diastole; Drug Therapy, Combination; Endpoint Determination; Female; Fumarates; Heart Rate; Humans; Hypertension; Male; Renin; Renin-Angiotensin System; Systole	2008
Comparison of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol. Revista espanola de cardiologia (English ed.), 2018, Volume: 71, Issue:9 Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Amides; Aorta, Thoracic; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Fumarates; Humans; Male; Marfan Syndrome; Prospective Studies; Pulse Wave Analysis; Renin; Treatment Outcome; Vascular Stiffness; Vasodilation	2018

Other Studies

1 other study(ies) available for atenolol and aliskiren

Article	Year
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:5 Topics: Amides; Amlodipine; Animals; Antihypertensive Agents; Apolipoproteins E; Atenolol; Atherosclerosis; Biphenyl Compounds; Blood Pressure; Cholesterol; Disease Models, Animal; Disease Progression; Female; Fumarates; Heart Rate; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin; Renin-Angiotensin System; Tetrazoles	2008

Article

Year

Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.

Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:5

Topics: Amides; Amlodipine; Animals; Antihypertensive Agents; Apolipoproteins E; Atenolol; Atherosclerosis; Biphenyl Compounds; Blood Pressure; Cholesterol; Disease Models, Animal; Disease Progression; Female; Fumarates; Heart Rate; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin; Renin-Angiotensin System; Tetrazoles

2008